Nevertheless, LRRC41 has been involved in cancer pathways elsewhere (e.g., hepatocellular carcinoma), and one integrative multi-omics study has identified that LRRC41 is co-expressed with a block of genes that are negatively related to tumor phenotypes [44]. This evidence concerns the gene LRRC41 and hepatocellular carcinoma.